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Letter to the Editor
Table 1
Primer Sequences and PCR Conditions Used
for Genotyping
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
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Transactivation Function of an ∼800-bp Evolutionarily
Conserved Sequence at the SHOX 3′ Region:
Implication for the Downstream Enhancer
To the Editor:
In the October 2005 issue of the Journal, Benito-Sanz
et al. (2005) reported an association of Le´ri-Weill dys-
chondrosteosis (LWD [MIM 127300]) with a novel class
of heterozygous pseudoautosomal region 1 (PAR1) de-
letions downstream of SHOX (short-stature homeobox-
containing gene [MIM 312865]) in 12 patients with two
copies of intact SHOX coding sequences. The deletions
were variable in size, with the smallest region of over-
lapping deletion (SRO) of ∼30 kb between DXYS10086
and rs7067102. The results—in conjunction with the re-
port of Flanagan et al. (2002) describing a monoallelic
SHOX expression in the bone marrow ﬁbroblasts taken
from the distal radius of a patient with LWD with two
copies of normal SHOX coding exons and hemizygosity
for a region around DXYS233 downstream of SHOX—
suggest the presence of a downstream enhancer for SHOX
transcription around the ∼30-kb SRO. Consistent with
this, Fukami et al. (2005) found that (1) a 240–350-kb
deletion includingDXYS233 is present in a heterozygous
status in a mother with LWD and two copies of intact
SHOX coding exons and (2) the same deletion is present
in a hemizygous status in her daughter with Langer me-
somelic dysplasia and a mosaic-ring X chromosomemiss-
ing the PAR1. Here, we report that the putative SHOX
enhancer may reside on an ∼800-bp evolutionarily con-
served sequence (ECS).
First, we analyzed the SHOX 3′ region in ﬁve Japanese
families in which the proband and one of the parents
had variable degrees of LWD and stature from short to
low normal in the presence of two copies of intact SHOX-
coding exons. The study was approved by the Institu-
tional Review Board Committee at the National Center
for Child Health and Development. Genotyping analy-
sis was performed with primers and methods shown in
table 1; results indicate that a deletion between SHOX-
SNP792 on the 3′ UTR and DXYS85 was shared by the
LWD-affected mother and daughter in family A and that
a deletion between rs5946324 and rs4504827 was com-
mon to the LWD-affected father and daughter in family
B (table 2 and ﬁg. 1A). Furthermore, FISH analysis was
performed with an RP13-167H21 BAC probe deﬁning
a region from rs5946324 toDXYS233 (EnsemblGenome
Browser); results show only a single signal in the mother
and the daughter of family A and an obviously different
signal intensity in the father and the daughter of family
B (ﬁg. 2). The results, together with our previous data
(Fukami et al. 2005), imply that an ∼40-kb region be-
tween rs5946326 and rs4504827 is the SRO in the Jap-
anese patients (SRO-J) (ﬁg. 1A). The SRO-J is in a close
agreement with the ∼30-kb SRO in the white patients
(SRO-W) (Benito-Sanz et al. 2005), and a region between
rs5946326 and rs7067102 is shared by all the patients
with SHOX 3′ deletions (ﬁg. 1A).
Next, we searched the UCSC Genome Browser for
the ECSs within the SROs. Seven ECSs (ECS1–ECS7)
were present within the SRO-J, whereas ECS6 and ECS7
were found to reside outside the SRO-W (ﬁg. 1B). ECS3–
ECS7 were well conserved in chicken and dog, which
preserve Shox, and were absent in mouse and rat, which
lack Shox (Clement-Jones et al. 2000; Ensembl Genome
Browser). ECS4 was also conserved in Fugu and zebra-
ﬁsh, which preserve Shox. By contrast, ECS1 was absent
in chicken, and ECS2 was conserved in mouse and rat.
Whereas ECS3 and ECS4 were not described in chim-
panzee, the sequence analysis remains poor for the Shox
3′ region in chimpanzee, in contrast to the detailed an-
alysis of that region in chicken and dog. These ﬁndings
suggest that ECS3–ECS5 can be regarded as candidate
regions harboring the putative downstream enhancer. In
this regard, since ECS3–ECS5 reside between rs5988437
and rs5946533 (UCSC Genome Browser), they should
be deleted from the patients in the three families deﬁning
the SRO-J (ﬁg. 1A).
Thus, we examined the transcription activity of ECS3–
ECS5 as well as ECS6 with the dual-luciferase reporter
assay system (Promega). Luciferase reporter constructs
containing each ECS (ECS3, 861 bp; ECS4, 824 bp; ECS5,
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Table 2
Summary of Polymorphism Analyses
LOCUSa POLYMORPHISMb
ALLELE OR POLYMORPHISM POSITION












c MS (CA)n 141/153 141/149 149 149/153 149/153
SHOXa/b 3/1239d SNP (C/G) C C G C/G NE
SHOXa/b 3/1248d SNP (G/A) G G A A/G NE
SHOX-SNP657e SNP (G/A) A A/G NE NE NE
SHOX-SNP792f SNP (T/G) T/G T T T T
rs5988407 SNP (C/T) C T NE NE NE
rs7055778 SNP (G/A) A A NE NE NE
rs5946324g SNP (C/G) G G G G/C G/C
rs5946325g SNP (C/T) T T T T NE
rs5946326g SNP (G/A) G G A G NE
rs5988281g SNP (C/G) C C G C NE
rs5946329g SNP (C/T) C C T C NE
rs5988432g SNP (C/T) C C C C NE
rs5946331g SNP (G/A) G G A G NE
rs5988437g SNP (C/G) C G G C NE
rs6644384g SNP (G/A) A A NE NE NE
rs5946336g SNP (G/A) A A G A NE
rs7067102g SNP (G/A) NE NE A A NE
rs5946533g SNP (C/T) NE NE T C NE
rs4504827g SNP (T/A) T T T/A T/A NE
rs5988299g SNP (C/T) NE NE C C NE
rs5988300g SNP (G/A) NE NE G A/G NE
rs5988301g SNP (C/G) NE NE G G/C NE
rs5988494g SNP (C/G) NE NE C C NE
DXYS233g MS (CA)n 273 279 273 273/283 273/279
rs4468091 SNP (G/A) G G G G A/G
rs5946712 SNP (G/A) G G G G G
DXYS85 4-bp ins/del 82 78/82 78/82 82 78/82
NOTE.—The loci present in two copies are underlined, and those not shared by the LWD-affected proband
and parent are in bold italics. A plus sign () p affected; a minus sign () p not affected; NE p not
examined.
a SHOXa/b3/1239 and SHOXa/b3/1248 are based on the Polymorphisms around SHOXDatabase,
SHOX-SNP657 and SHOX-SNP792 are based on the study by Flanagan et al. (2002), and the remaining
loci are based on dbSNP and dbSTS databases.
b MS p microsatellite.
c Located in the SHOX 5′ UTR.
d Located between exon 6a inherent to SHOXa and exon 6b speciﬁc to SHOXb.
e Silent polymorphism on exon 6b.
f Located in the SHOX 3′ UTR.
g Loci included in the RP13-167H21 BAC probe used for FISH analysis.
441 bp; ECS6, 634 bp) inserted into the 3′ region of the
luciferase gene were created using the pGL3 vector with
the SV40 promoter or the human SHOX promoter on
exon 2 (432 to 5 bp) (Blaschke et al. 2003) (ﬁg. 1B).
The U2OS osteosarcoma cell line expressing SHOX (Rao
et al. 2001) was transfected using lipofectamine (Invi-
trogen) with each reporter vector together with the pRL-
CMV vector used as an internal control for the trans-
fection, and luciferase assays were performed 36 h later.
After the experiments were performed ﬁve times, the nor-
malized luciferase activity was found to be signiﬁcantly
increased only when the reporter vector with ECS4 and
the SHOX promoter was transfected to U2OS cells
(empty vs. ECS4; by t test) (ﬁg. 1B). This im-Pp .011
plies that the putative SHOX enhancer resides in ECS4
and interacts with the SHOX promoter on exon 2.
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Figure 1 A, PAR1 deletions in the SHOX downstream region. Top, Pedigrees of families A and B. LWD is exhibited by the mother and
the daughter in family A and by the father and the daughter in family B. The height of each subject is expressed as an SD score. Bottom,
Deletion maps of the SHOX 3′ region. In families A and B, the blackened segments represent the disomic regions, the unblackened segments
depict the monosomic regions, and the striped segments indicate the dosage-unknown region in which the breakpoints should exist. The physical
distance (kb) from the Xp/Yp telomere (“Tel”) is shown below the horizontal line. The results of the present study and those reported by Fukami
et al. (2005) indicate that the SRO-J spans ∼40 kb in physical length and is largely similar to the SRO-W reported by Benito-Sanz et al. (2005).
B, Functional analysis of the ECSs. Top, Seven ECSs (ECS1–ECS7) are identiﬁed in the SRO-J (UCSC Genome Browser). Bottom, Transcription
analysis of ECS3–ECS6. A luciferase reporter construct has been created with the SV40 or the human SHOX promoter, and each ECS inserted
into the 3′ region of the luciferase gene (“Luc”). Only the combination of the SHOX promoter and ECS4 has signiﬁcantly increased the luciferase
activity.
Figure 2 Results of the FISH analysis. The legend is available
in its entirety in the online edition of The American Journal of Human
Genetics.
Finally, we searched ECS4 for potential binding sites
for transcription factors relevant to bone development,
using the MATINSPECTOR, TESS, and TFSEARCH
programs. The putative binding sites with the maximum
core similarity of 1.0 and a matrix similarity 10.75 were
identiﬁed for HOXA9, HOXB9, PBX1, and MEIS1, as
well as for PBX1-HOXA9 and MEIS1-HOXA9 hetero-
dimers, which are known to be involved in limb devel-
opment (Mercader et al. 1999; Shanmugam et al. 1999;
Za´ka´ny and Duboule 1999) (ﬁg. 3). Thus, the sequence-
speciﬁc DNA binding of such a factor(s) might mediate
the enhancer activity for SHOX. However, other poten-
tial binding sites were also detected for various transcrip-
tion factors, and the relevance to skeletal development
has not been studied or excluded in most of the transcrip-
tion factors. In addition, the binding sites remain uniden-
tiﬁed for many transcription factors. Thus, further stud-
ies are necessary to deﬁne the enhancer sequence.
In summary, the results suggest that the∼800-bp ECS4
harbors the putative downstream enhancer for SHOX
transcription. This information will provide a useful clue
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Figure 3 Nucleotide sequence of ECS4 and putative binding sites
for several transcription factors relevant to skeletal development. The
human sequence is aligned with the chicken sequence.
for the clariﬁcation of the molecular network involved
in SHOX-dependent skeletal development.
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Web Resources
The URLs for data presented herein are as follows:
dbSNP, http://www.ncbi.nlm.nih.gov/projects/SNP/
dbSTS, http://www.ncbi.nlm.nih.gov/dbSTS/
Ensembl Genome Browser, http://www.ensembl.org/
MATINSPECTOR, http://www.genomatix.de/products/MatInspector/
MatInspector3.html
Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.nlm
.nih.gov/Omim/ (for LWD and SHOX)
Polymorphisms around SHOX Database, http://www.le.ac.uk/genetics/
ajj/SHOX/mapdetails.html
TESS: Transcription Element Search System, http://www.cbil.upenn
.edu/tess/
TFSEARCH, http://www.cbrc.jp/research/db/TFSEARCH.html
UCSC Genome Browser, http://genome.ucsc.edu/
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